Comparative effect of topical diclofenac and topical dexamethasone on anterior chamber flare and postoperative pain following rhegmatogenous retinal detachment surgery
- PMID: 26757935
- DOI: 10.1007/s10792-015-0168-1
Comparative effect of topical diclofenac and topical dexamethasone on anterior chamber flare and postoperative pain following rhegmatogenous retinal detachment surgery
Abstract
The purpose of this study is to compare the effect of topical diclofenac and topical dexamethasone on anterior chamber flare and postoperative pain following rhegmatogenous retinal detachment (RRD) surgery. This prospective study included 40 eyes of 40 patients treated for RRD. Twenty-eight patients underwent scleral buckling and 12 patients underwent 20-gauge pars plana vitrectomy (PPV). For each surgical procedure, patients were postoperatively randomly divided into two groups: the first group received topical dexamethasone phosphate 0.1 % four times daily for 28 days; the second group received topical diclofenac sodium 0.1 % three times daily for 28 days. The inflammatory reaction in the anterior chamber was measured with laser flare photometry preoperatively and 1, 7, 14, 28, and 90 days postoperatively. Pain level was evaluated with Scott's visual analog scale at day 1, 7, 14, and 28 postoperatively. For patients treated with scleral buckling, there was no significant difference between the two groups regarding mean aqueous flare at day 1 (p = 0.096), day 7 (p = 0.435), day 14 (p = 0.510), day 28 (p = 0.583), and day 90 (p = 0.423). The group who received diclofenac had significantly lower pain score at days 7, 14, and 28 (p = 0.048, p = 0.017, and p = 0.028, respectively). For patients treated with PPV, there was no significant difference between the two groups regarding mean aqueous flare at day 1 (p = 0.400), day 7 (p = 0.728), day 14 (p = 0.843), day 28 (p = 0.939), and day 90 (p = 0.568). Patients who received diclofenac had significantly lower pain score at days 7, 14, and 28 (p = 0.032, p = 0.030, and p = 0.023, respectively). Topical diclofenac seems to be as potent as topical dexamethasone in managing postoperative inflammatory response induced by surgery for RRD with better analgesic effect. Both of them are consequences of blood-aqueous barrier and blood-retinal barrier breakdown.
Keywords: Blood-aqueous barrier; Dexamethasone; Diclofenac; Laser flare photometry; Postoperative pain; Rhegmatogenous retinal detachment surgery.
Similar articles
-
Diclofenac drops to treat inflammation after cataract surgery.Acta Ophthalmol Scand. 2000 Aug;78(4):421-4. doi: 10.1034/j.1600-0420.2000.078004421.x. Acta Ophthalmol Scand. 2000. PMID: 10990044 Clinical Trial.
-
Influence of topical treatment on epithelial wound healing and pain in the early postoperative period following photorefractive keratectomy.Acta Ophthalmol Scand. 1999 Apr;77(2):135-8. doi: 10.1034/j.1600-0420.1999.770203.x. Acta Ophthalmol Scand. 1999. PMID: 10321525 Clinical Trial.
-
Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation.Ophthalmology. 1999 Feb;106(2):223-31. doi: 10.1016/S0161-6420(99)90060-X. Ophthalmology. 1999. PMID: 9951469 Clinical Trial.
-
Diclofenac Versus Dexamethasone Following Strabismus Surgery: A Systematic Review and Meta-Analysis.J Ocul Pharmacol Ther. 2021 Jul-Aug;37(6):343-353. doi: 10.1089/jop.2020.0133. Epub 2021 Apr 30. J Ocul Pharmacol Ther. 2021. PMID: 33944620
-
Control of intraocular inflammation associated with cataract surgery.Curr Opin Ophthalmol. 2000 Feb;11(1):3-6. doi: 10.1097/00055735-200002000-00002. Curr Opin Ophthalmol. 2000. PMID: 10724825 Review.
Cited by
-
Inflammatory responses after vitrectomy with vitreous substitutes in a rabbit model.Graefes Arch Clin Exp Ophthalmol. 2019 Apr;257(4):769-783. doi: 10.1007/s00417-019-04242-0. Epub 2019 Jan 17. Graefes Arch Clin Exp Ophthalmol. 2019. PMID: 30656473
-
Preoperative, Intraoperative and Postoperative Corticosteroid Use as an Adjunctive Treatment for Rhegmatogenous Retinal Detachment.J Clin Med. 2020 May 21;9(5):1556. doi: 10.3390/jcm9051556. J Clin Med. 2020. PMID: 32455658 Free PMC article. Review.
-
In vivo evaluation of a Nano-enabled therapeutic vitreous substitute for the precise delivery of triamcinolone to the posterior segment of the eye.Drug Deliv Transl Res. 2024 Oct;14(10):2668-2694. doi: 10.1007/s13346-024-01566-1. Epub 2024 Mar 22. Drug Deliv Transl Res. 2024. PMID: 38519828 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous